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Abstract
Sporotrichosis is a chronic infectious disease affecting both humans and animals. For many years, this subcutaneous
mycosis had been attributed to a single etiological agent; however, it is now known that this taxon consists of a
complex of at least four pathogenic species, including Sporothrix schenckii and Sporothrix brasiliensis. Gp70 was
previously shown to be an important antigen and adhesin expressed on the fungal cell surface and may have a key
role in immunomodulation and host response. The aim of this work was to study the virulence, morphometry, cell
surface topology and gp70 expression of clinical isolates of S. brasiliensis compared with two reference strains of S.
schenckii. Several clinical isolates related to severe human cases or associated with the Brazilian zoonotic outbreak
of sporotrichosis were genotyped and clustered as S. brasiliensis. Interestingly, in a murine subcutaneous model of
sporotrichosis, these isolates showed a higher virulence profile compared with S. schenckii. A single S. brasiliensis
isolate from an HIV-positive patient not only showed lower virulence but also presented differences in cell
morphometry, cell wall topography and abundant gp70 expression compared with the virulent isolates. In contrast,
the highly virulent S. brasiliensis isolates showed reduced levels of cell wall gp70. These observations were
confirmed by the topographical location of the gp70 antigen using immunoelectromicroscopy in both species. In
addition, the gp70 molecule was sequenced and identified using mass spectrometry, and the sequenced peptides
were aligned into predicted proteins using Blastp with the S. schenckii and S. brasiliensis genomes.
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Introduction
Sporotrichosis is the most frequent subcutaneous mycosis in
Latin America [1-3]. Until recently, this disease had always
been attributed to a single etiological agent, the dimorphic
fungus Sporothrix schenckii [4,5]. A recent phylogenetic study
proposed that S. schenckii is actually a complex of cryptic
species, at least five of which have clinical interest: S. globosa,
S. brasiliensis, S. luriei, S. mexicana and S. schenckii sensu
stricto [6-8]. However, when several isolates were genotyped
more recently using different markers, it was found that S.
mexicana seems to cluster with environmental species in the
Sporothrix pallida complex, and these species were proposed
to be accidentally pathogenic [9]. This hypothesis was
supported by thermotolerance evaluation of the isolates
analyzed compared with clinical isolates of the S. schenckii
complex [10]. Phenotypic and genotypic features of different
isolates within this complex were associated with their
geographical distribution, virulence capacity or clinical
manifestation of sporotrichosis [11-14]. In addition, several
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reports have shown that more than one species can be isolated
within the same endemic area [1,15-17]. Two pathogenic
species have been associated with endemic areas in Brazil, S.
schenckii and S. brasiliensis [10,15].
A large variety of clinical manifestations of sporotrichosis
have been described, but there is no clear explanation for the
incidence of severe and disseminated forms of sporotrichosis
in immunologically healthy patients [18]. In addition to the
presence of more than one pathogenic species within the S.
schenckii complex, other biological factors inherent to the
pathogen may be relevant to the outcome of an infectious
disease, as proposed for other pathogens [19]. Therefore,
the multifactorial nature of the virulence of pathogenic
microorganisms should be considered. Recently, it was shown
that zoonotic outbreaks registered in Brazil are caused mainly
by S. brasiliensis, which is recognizably more thermotolerant
than the other species of the Sporothrix complex. However,
other relevant factors for the pathogenesis of these organisms
need to be elucidated, as the mechanisms involving the
colonization and rapid aggravation of the disease are still not
clearly understood. Other virulence factors already known in S.
schenckii are extracellular enzymes [20-22], adhesins [23,24]
and melanin [25,26]. The major adhesin described on the cell
surface of S. schenckii, gp70, has been shown to mediate the
binding of yeast cells to the dermal matrix and to fibronectin
[24,27]. Gp70 also plays a pivotal role as an antigen, which can
modulate the host immune response [28].
Little is known about the virulence factors of isolated cryptic
species of the Sporothrix schenckii complex. In this context, the
emergence and pathogenicity of S. brasiliensis leads to the
necessity to elucidate the virulence mechanisms of this new
species [14,29].
The aim of the present work is to study the virulence,
morphometry, cell surface ultrastructure and gp70 cell wall
expression of S. brasiliensis clinical isolates compared with S.
schenckii reference strains. In addition, the gp70 peptide
sequence was revealed based on the genome database of
both species.
Materials and Methods
Ethics statement
All procedures were performed in strict accordance with
Brazilian Federal Law 11,794 for Procedures of the Scientific
Use of Animals and with the National Health Animal Care
Guidelines. The animal experiments were performed to
minimize suffering of the animals and were approved by the
Institutional Ethics Committee of Instituto de Biologia Roberto
Alcantara Gomes, Universidade do Estado, Rio de Janeiro,
Brazil (CEA-IBRAG-UERJ, process number CEA/027/2010).
Microorganism and culture conditions
All isolates used throughout this study are listed in Table 1,
including the geographical, genotype and clinical origin when
pertinent. The yeast phase of each strain was obtained by
cultivation in Brain Heart Infusion broth (Oxoid, Hampshire, UK)
at 37 °C for 7 days, as previously described [30]. For in vivo
experiments, the mycelia phase of each strain was grown in
Sabouraud broth (Difco, Detroit, USA) for 5 days at room
temperature, and the conidia were isolated from hyphae using
a Buchner funnel and gauze (see Figure S2). For the scanning
electron microscopy (SEM) experiments, the mycelial phase of
S. schenckii isolates 1099-18 and IPEC 15383 and S.
brasiliensis isolates IPEC 17943 and 5110 were cultivated in
Sabouraud-agar discs placed between coverslips and
incubated at room temperature for 15 days.
Genotyping of clinical isolates of the Sporothrix genus
About 500 mg of each isolate in mycelium form was
macerated in liquid nitrogen using pestle and mortle. DNA
extractions were performed using the DNAeasy Plant Mini Kit
(Qiagen, Venlo, NLD). DNA integrity was checked by
electrophoresis in 0.8% agarose gel stained with 0,5µg/ml of
ethidium bromide and samples were quantified in NanoDROP
2000c (Thermo). Primers were designed for amplification of the
calmodulin (cal) gene (forward 5'
GARTWCAAGGAGGCCTTCTC 3' and reverse 5'
TTTTGCATCATGAGTTGGAC) for species delineation [6].
PCR reactions were carried out using 25 ng of genomic DNA
from each of 7 isolates. The sequences of the amplicons were
deduced by automatic capillary Sanger sequencing in a
Table 1. Clinical information and genotype of Sporothrix spp. isolates used in the study.
Isolate Host / Clinical Form Geographical Origin (State, Country) Genotype GenBank Accession Number for cal locus
1099-18 Human / LCa USA S. schenckii JF313360 –this study
IPEC 15383 Human / LC and ECa (osteoarticular) Rio de Janeiro, Brazil S. schenckii JF313361 - this study
IPEC 17943 HIV+ Human/FCa and meningitis Rio de Janeiro, Brazil S. brasiliensis JF313362 - this study
5110 Cat / Cutaneous Rio de Janeiro, Brazil S. brasiliensis JF313351 - this study
Ss54 (CBS132990) Cat / NDb Rio Grande do Sul, Brazil S. brasiliensis Rodrigues et al., 2013
HUPE 114500 Human / Meningeal Rio de Janeiro, Brazil S. brasiliensis KF048980 - this study
HUPE 114158 Human / cutaneous with facial destruction Rio de Janeiro, Brazil S. brasiliensis KF048981 - this study
UFTM01 Human /CDa and EC (endocarditis) Minas Gerais, Brazil S. brasiliensis Silva-Vergara et al., 2012
a-LC_Lymphocutaneous sporotrichosis; EC_Extracutaneous; FC_Fixed cutaneous; CD_cutaneous disseminated.b-ND - Not described.
doi: 10.1371/journal.pone.0075656.t001
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MegaBACETM 500 machine using the DYEnamicTM ET Dye
Terminator Kit (GE Healthcare, Piscataway, NJ, USA). The
fragments were sequenced on both strands to increase the
quality of the sequence data (phred>30). To assess the
phylogenetic distribution of the isolates, sequences of the cal
locus from type strains of S. schenckii (AM117437), S.
brasiliensis (AM116899) and S. globosa (AM116908) were
accessed from GENBANK and added to the analysis. The
sequences were compared with the NCBI nucleotide databank
using the Blastn tool. Sequence alignments were performed
using the ClustalW algorithm [31] implemented in the BioEdit
software [32]. The retrieved alignments were manually edited
to avoid mispaired bases. Phylogenetic analysis was
conducted in MEGA5 [33]. The phylogenies were inferred using
the Maximum Likelihood and Neighbor-Joining methods, and
bootstrap searches were performed to check branch fidelity.
Experimental infection
Groups of 10 male BALB/c mice (2 months old and weighing
approximately 30 g) were maintained in temperature-controlled
rooms with ad libitum access to food and water throughout the
experiments. Each mouse was subcutaneously inoculated in
the dorsal sacral region with 107 conidia suspended in sterile
PBS (Figure S2). The uninfected control group was injected
with sterile PBS. To confirm the cell count of each inoculum, an
appropriate sample of the conidia cell suspension was plated
onto BHI (Brain Heart Infusion) agar plates; after 7 days of
incubation, the number of colonies was determined. Infected
and control mice were monitored daily for at least 40 days to
evaluate the progression of the disease. The parameters
determined were the extension of the primary skin lesion and
the CFU. Three mice of each group were euthanized 40 days
post-infection, and the skin lesion, lungs and spleen were
removed to assess the fungal load, to evaluate dissemination
to internal organs and to perform histopathological analysis, as
detailed below.
Histopathology
Skin lesions specimens were collected, fixed in 10% buffered
formalin, processed, embedded in paraffin and sectioned in a
microtome. Slides were analyzed by one pathologist, blind to
the fungus species and strain. Fungal burden was analyzed in
Gomori-Grocott methenamine-silver (GMS) stained slides.
Assessment of tissue reaction was performed on hematoxylin
and eosin (HE)-stained slides and included observation of the
intensity and organization of neutrophilic and phagocytic
mononuclear infiltrates in semi-quantitative scales. Fungal
localization in tissue was observed in PAS-stained slides, and
the expected extracellular locations were in abscesses, in
necrotic tissue and in normal tissue. Furthermore, intracellular
fungal structures were also searched for, especially in
phagocytic mononuclear cells.
Preparation of cell wall extracts
Cell wall protein extraction was performed as previously
described [34]. Briefly, yeast cells were collected and washed
with ice-cold 25 mM Tris/HCl buffer (pH 8.5), likewise used in
the subsequent extraction step. Cells were further incubated
with an extraction solution (2 mM DTT, 40 µM leupeptin, 1mM
PMSF and 5 mM EDTA in 25 mM Tris/HCl, pH 8.5) at 4 °C for
2 h with mild agitation. The supernatant containing the cell
surface proteins was collected and concentrated. The proteins
were then precipitated with trichloroacetic acid/acetone as
previously described [35] and quantified by Bradford assay
(Bio-Rad, Hercules, CA, USA).
Western blot
A monoclonal antibody raised against the gp70 antigen [28],
mAb P6E7, was used to evaluate the gp70 expression on the
surface of S. schenckii and S. brasiliensis.
Samples of 5 µg of the cell wall extracts from two reference
strains of S. schenckii and six S. brasiliensis isolates (Table 1)
were separated by electrophoresis in a 12% SDS-
polyacrylamide gel [36]. Subsequently, proteins were
electrotransferred to Hybond ECL nitrocellulose membranes
(GE Healthcare) at 50 V for 120 min in 20% methanol, 25 mM
Tris, 96 mM glycine (pH 8.3) in a Mini-Protean II Cell (Bio-Rad,
USA). Next, the membranes were blocked with 5% skim milk in
TBS-T (50 mM Tris, 0.15 M NaCl, 0.1% Tween 20), washed in
1% skim milk in TBS-T and incubated with mAb P6E7 1:1000
for 2 h at room temperature under constant agitation. The
membrane was washed in 1% skim milk in TBS-T and
incubated with horseradish peroxidase (HRP)-conjugated anti-
mouse IgG antibodies diluted 1:4000 according to
manufacturer instructions (Kirkegaard & Perry Laboratories,
Gaithersburg, MD, USA). After a washing step, the membrane
was developed using an ECL Plus kit (GE Healthcare), and the
images were obtained using a Typhoon Trio scanner (GE
Healthcare).
Proteomic identification of the 70 kDa cell surface
component
For the identification of gp70, cell wall extracts of S.
schenckii and S. brasiliensis and a highly purified gp70 antigen
from strain M-64 were used. Protein bands recognized by mAb
P6E7 were manually excised from Coomassie-stained SDS-
PAGE 1D gels. The gel pieces were destained with ultrapure
water overnight, washed twice with 25mM ammonium
bicarbonate/50% acetonitrile (ACN) for 30 min, shrunk with
100% ACN for 10 min and vacuum-dried. The gel pieces were
then incubated with 12.5 ng/µl sequencing-grade trypsin
(Promega, Madison, WI, USA) in 25 mM ammonium
bicarbonate overnight at 37°C. After digestion, the
supernatants were separated. Peptides were extracted from
the gel pieces first into 0.5% trifluoroacetic acid/50% ACN twice
for 1 h and then into 100% ACN once for 20 min. All extracts
were pooled, and the volume was reduced using a SpeedVac.
The cell wall extraction and identification protocols were
previously described by Kubitschek-Barreira et al. [34]
After digestion, the supernatant was collected, and 0.5 µl
was spotted on a MALDI target plate (Applied Biosystems,
Foster City, CA, USA), mixed subsequently with 0.5 µl of matrix
(3 mg/ml of α-cyano-4-hydroxy-trans-cinnamic acid; Sigma, St.
Louis, MO, USA) diluted in 0.1% trifluoroacetic acid-
acetonitrile/H 2O (1:1, v/v) and allowed to air dry for 5 min at
room temperature. The samples were analyzed using a 5800
Cell Wall Gp70 and Virulence in S. brasiliensis
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AB Sciex ToF/ToF 5800 mass spectrometer (Applied
Biosystems) in manual mode. Initially, a MALDI MS spectrum
was acquired from each spot (700 shots/spectrum), and the ten
peaks with a major signal-to-noise ratio in each spectrum were
manually selected for MS/MS analysis (4,000 shots/spectrum).
All mass spectra were externally calibrated using the 4700
Proteomics Analyzer Mass Standards Kit (Applied Biosystems).
The proteins were identified using the Protein Pilot software to
perform a search against the S. schenckii and S. brasiliensis
genome database, constructed with curated genome
information (unpublished data). A False Discovery Rate (FDR)
of 1% was applied to ensure the quality of the data. The gp70
sequences of S. schenckii and S. brasiliensis were aligned to
observe possible differences in the protein sequences between
these two species using the NCBI Blastp tool. The identified
sequences of S. schenckii and S. brasiliensis gp70 were
deposited at EMBL-EBI.
Moreover, the sequences of gp70 were analyzed using
several predictors (EnsembleGly, NetPhos 2.0, SignalIP 4.1
and BigPI) to search for glycosylation and phosphorylation
sites and for a secretion signal and GPI anchor. To evaluate
the phylogenetic distribution in other Sordariomycetes, the
predicted amino acid sequences of S. schenckii and S.
brasiliensis were compared with the NCBI protein database
using Blastp, and homologues from other Sordariomycete fungi
were used for phylogenetic analysis. Retrieved sequences
were aligned and manually edited to avoid mispaired bases.
Phylogenetic analyses were conducted in MEGA5 [33] using
the Maximum Likelihood method, and the best amino acid
evolutive model was selected under AIC (Akaike Information
Criterion). Bootstrap searches were performed to check branch
fidelity and were added next to the branches. Functional
analysis of the gp70 protein sequence was performed using
IterPro (http://www.ebi.ac.uk/interpro/), and domains and
important sites were annotated.
Scanning electron microscopy
The yeast and/or the mycelial phases of the reference
isolates of S. schenckii (1099-18, IPEC 15383) and clinical
isolates of S. brasiliensis (IPEC 17943 and 5110) were fixed
with a solution containing 2.5% glutaraldehyde, 4% freshly
prepared formaldehyde in 0.1 M cacodylate buffer (pH 7.2) for
1 h at room temperature and then adhered on coverslips
placed in 24-well plates with poly-L-lysine. The coverslips were
washed with cacodylate buffer and postfixed with 1% OsO4,
0.8% K4Fe(CN)6·3H2O for 1 h. Next, the coverslips were
washed, dehydrated with ethanol, critical-point dried with CO2
and coated with gold. Observations were performed on a field
emission Jeol JSM6340-F or FEI Quanta 250 scanning
electron microscope. The yeast and conidial area was
measured using the ImageJ software (National Institutes of
Health, Bethesda, MD USA).
For the interaction assays of the isolates with mAb P6E7, the
yeast cells were fixed with a solution containing 0.1%
glutaraldehyde, 1% formaldehyde in 0.1 M cacodylate buffer
(pH 7.2) for 1 h at room temperature. After washing, the cells
were blocked with NH4Cl in cacodylate buffer for 30 min at
room temperature. The cells were washed and then adhered
on coverslips placed in 24-well plates with poly-L-lysine. The
coverslips were incubated with mAb P6E7 (100 µg ml-1) for 1 h
at 37 °C. The cells were then washed and incubated with 15
nm colloidal gold-labeled anti-mouse IgG diluted 1:50 in PBS
for 1 h at 37 °C. The yeasts were postfixed, dehydrated, dried
and coated with carbon. Observations were made on a field
emission Jeol JSM6340-F scanning electron microscope fitted
with a backscatter electron detector.
Transmission electron microscopy
Yeast cells of S. schenckii and S. brasiliensis clinical isolates
were fixed with a solution containing 0.1% glutaraldehyde, 1%
freshly prepared formaldehyde in 0.1 M cacodylate buffer(pH
7.2) for 1 h at room temperature. After washing, the cells were
blocked with NH4Cl in cacodylate buffer for 30 min at room
temperature. Samples were then washed in cacodylate buffer,
dehydrated in a graded series of ethanol and embedded in
Unicryl resin. Ultrathin sections were incubated with mAb P6E7
(25 µg ml-1) in PBS for 1 h, at 37 °C. After washing, the
sections were incubated with 10 nm colloidal gold-labeled anti-
mouse IgG diluted 1:100 in PBS for 1 h at 37 °C and then
stained with aqueous uranyl acetate and alkaline lead citrate
and examined in a ZEISS 100 Transmission Electron
Microscope.
Statistical analysis
Statistical analysis was performed by variance analysis
(ANOVA) followed by Tukey’s post-test to compare the
average lesion diameters among the experimental groups. For
the other data, statistical analysis was assessed by analysis of
variance followed by Student’s t-test. In all cases, P<0.05 was
considered statistically significant.
Results
Phylogenetic analysis of the Sporothrix isolates
The phylogenetic distribution of the isolates analyzed places
them into S. schenckii and S. brasiliensis species. The isolates
HUPE 114158, HUPE 114500, 5110, Ss54 and IPEC 17943
clustered together with the S. brasiliensis type strain IPEC
16490T with high bootstrap values, sharing 99-100% sequence
identity. Isolates IPEC 15383 and 1099-18 clustered with the S.
schenckii type strain CBS 359.36T, supported by high
bootstrap values, sharing 99-100% sequence identity
(Supplementary material - Figure S1). The strain details such
as host, origin and Genbank accession number are shown in
Table 1.
Virulence of S. brasiliensis clinical isolates in a
subcutaneous murine model
To evaluate the pathogenicity of the six clinical isolates of S.
brasiliensis and to compare them with two reference strains of
S. schenckii (1099-18, IPEC15383), as detailed in Table 1, a
subcutaneous murine model of sporotrichosis was established
as illustrated in the supplementary material (Figure S2). Male
BALB/c mice were subcutaneously inoculated with 107 conidia
of each strain, and the progression of the disease was followed
Cell Wall Gp70 and Virulence in S. brasiliensis
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up to 40 days post-infection. The progression of subcutaneous
sporotrichosis was determined by the evolution of the primary
skin lesion (Figure 1A) and the development of secondary
lesions (Table 2). The fungal burden in the primary
subcutaneous lesion was determined by CFU counts followed
by histopathology (Figure 1B, Figures S3 and S4). Additionally,
possible dissemination to the internal organs (spleen and
lungs) of the infected animals was investigated (Table 2). In
general, compared with the S. schenckii reference strains, the
S. brasiliensis clinical isolates exhibited high pathogenicity with
a single exception, IPEC 17943 isolate (Figure 1). The S.
brasiliensis clinical isolates Ss54, 5110 and HUPE 114158
were shown to induce progressive and/or persistent skin
lesions in mice and a higher capacity to disseminate (Figure 1A
and Table 2) and were thus considered hypervirulent. The S.
brasiliensis UFTM 01 and HUPE 114500 isolates presented
mild virulence. A single S. brasiliensis isolate, IPEC 17943,
showed a lower virulence profile and behaved similarly to the
S. schenckii reference strains (Figure 1A and Table 2).
Independently of the virulence profile, it was possible to
recover the fungus from the primary skin lesion 40 days post-
infection, although a higher fungal burden was observed for the
more virulent strains (Figure 1B). Interestingly, for all mice
infected with the lower virulence strains, the appearance of
secondary lesions was not observed. In contrast, the 5110
isolate of S. brasiliensis showed a high dissemination capacity
with a significant fungal load observed in the lungs and spleen,
leading to 100% mortality of infected mice within 60 days post-
infection (Table 2).
Histopathological analysis indicates that the S. brasiliensis
strains showed the formation of few or no granulomes in the
infected tissues with the exception of the lower virulence
IPEC17943 strain. In this specific case, the granulome
formation in skin lesions was similar to the aspect observed for
S. schenckii (supplementary material - Figure S4).
Interestingly, only S. schenckii yeasts were found inside
phagocytes (data not shown).
Morphological comparative analysis of S. schenckii
and S. brasiliensis
For the morphometric and ultrastructural studies, two isolates
of each species were selected. In the specific case of S.
brasiliensis, the isolates showing the lower and higher
virulence profiles were chosen. The S. schenckii 1099-18 and
IPEC 15383 strains were considered reference model strains,
as they have been extensively studied previously [4,24]. Both
strains were already deposited in the American Type Culture
Collection (ATCC).
To compare the morphology between the clinical isolates of
S. schenckii and S. brasiliensis, morphometric analysis was
performed using scanning electron microscopy and ImageJ
analysis, as detailed in the methodology. The conidia of both S.
schenckii clinical isolates did not differ in size, presenting an
area of 2.78 ± 0.36 and 2.86 ± 0.59 µm2 for isolates 1099-18
and IPEC 15383, respectively (Table 3, Figure 2). However,
the conidia of S. brasiliensis isolates varied statistically in size
(p < 0.05), featuring an area of 3.07 ± 0.61 and 3.81 ± 0.58 µm2
for IPEC 17943 and 5110, respectively (Table 3, Figure 2).
Furthermore, S. schenckii isolates presented elongated oval
conidia, while S. brasiliensis isolates showed simply oval
conidia (Figure 2). In addition, the 1099-18 isolate (S.
schenckii) presented predominantly sessile conidia (Figure 2A),
while the IPEC 15383 isolate of S. schenckii and IPEC 17943
of S. brasiliensis showed sympodial conidia (Figure 2B and C).
In contrast, the 5110 isolate of S. brasiliensis presented both
sessile and sympodial conidia (Figure 2D).
Yeast cell morphometry revealed no differences in size
among 1099-18, IPEC 15383 (S. schenckii) and 5110 (S.
brasiliensis) isolates; however, the yeast cells of the less
virulent S. brasiliensis isolate, IPEC 17943, were significantly
smaller (Table 4, Figure 3). Moreover, image analysis revealed
a pleomorphism of the yeast-like phase, which varied from oval
to elongated (cigar-shaped), independent of the species and
isolate origin (Figure 3). For the S. brasiliensis IPEC 17943
isolate, a predominance of elongated yeast cells was observed
(Figure 3C), while the 5110 isolate contained oval yeast cells
(Figure 3D).
Cell wall topography and gp70 expression
High resolution scanning electron microscopy images
demonstrated a similar topography of the yeast cell surface for
both S. schenckii isolates (Figure 4, panels A/B and E/F). In
addition, a smooth irregular cell surface indicating the presence
of an abundant amorphous material was observed in the S.
brasiliensis 5110 isolate (Figure 4D and H). Nevertheless, this
isolate has a denser surface compared with the S. schenckii
isolates. In contrast, the S. brasiliensis IPEC 17943 isolate
presents a compact yeast cell surface (Figure 4C and G). In
this case, some cells showed fractured outer cell wall areas, as
illustrated in Figure 4G.
In parallel, the yeast cell surface of S. schenckii and S.
brasiliensis were analyzed by field emission scanning electron
microscopy. Yeast cells of all four isolates were incubated with
the anti-gp70 monoclonal antibody followed by labeling with a
15-nm colloidal gold-conjugated anti-mouse IgG. A
backscattered electron detector was used to reveal the sites
where the gold particles were attached, showing a positive
labeling on the cell surface of both S. schenckii isolates (Figure
5E-M). Interestingly, a higher density of antibody binding sites
was also observed for the yeast cells of S. brasiliensis IPEC
17943 isolate (Figure 5L). In contrast, poor labeling was
observed on the yeast cell surface of the S. brasiliensis 5110
isolate (Figure 5M). In a western blot assay, a weakly positive
band recognized by the anti-gp70 mAb P6E7 was observed on
the 5110 cell surface extract only when a three-fold protein
concentration was loaded on the 1D gel (Figure 5D) compared
with the other isolates (Figure 5A-C). These observations
corroborate the SEM results.
Once differences in gp70 expression were observed among
S. brasiliensis isolates showing divergent virulence profiles, the
presence of gp70 in cell wall extracts of all S. brasiliensis
isolates was comparatively analyzed by western blot using a
similar protein load (Figure 6). As expected, for S. schenckii
reference strains, a positive band with an apparent MW in the
range of 60-70 kDa was detected. Interestingly, the S.
Cell Wall Gp70 and Virulence in S. brasiliensis
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brasiliensis clinical isolates exhibited almost no reactive band,
excepting the IPEC 17943 strain (Figure 6, lane 3).
Figure 1.  Virulence profile in a murine model of cutaneous sporotrichosis.  BALB/c mice were subcutaneously infected with
107 conidia of clinical isolates of S. schenckii or S. brasiliensis. (A) Evolution of primary lesions in the dorsal sacral region of mice
infected with S. brasiliensis and S. schenckii isolates. (B) Fungal load of the primary cutaneous lesions determined 40 days post-
infection. a p<0.05 relative to 1099-18 isolate; b p<0.05 relative to IPEC 15383 isolate; c p<0.05 relative to IPEC 17943 isolate;
dp<0.05 relative to Ss54 isolate; e p<0.05 relative to HUPE 114158 isolate.
doi: 10.1371/journal.pone.0075656.g001
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Subcellular distribution of gp70 in S. schenckii and S.
brasiliensis
The subcellular distribution of gp70 in S. schenckii and S.
brasiliensis yeast cells was investigated using transmission
electron microscopy. Images of yeast sections incubated with
mAb P6E7 and a 10-nm colloidal gold-conjugated anti-mouse
IgG revealed higher positive labeling on the cell wall of IPEC
17943 S. brasiliensis yeast cells (Figure 7C) and in both S.
schenckii strains (Figure 7A and B). In addition, the images
demonstrated the low labeling of the cell wall of the S.
brasiliensis 5110 isolate (Figure 7D), which corroborates the
scanning electron microscopy and western blot data.
Furthermore, the presence of gold particles in the
intracellular space suggests that gp70 is distributed in several
subcellular compartments and is not restricted to the cell
surface (Figure 7). Interestingly, a positive labeling of gp70 in
the extracellular space was observed (Figure 7C, amplified
area), suggesting that gp70 can also be secreted.
Identification and in silico characterization of the cell
surface gp70
The identification of the gp70 cell wall antigen was performed
for both S. schenckii and S. brasiliensis using a 1D-
MALDI/TOF/TOF approach. From the cell wall extracts, the
corresponding bands that were recognized by the monoclonal
antibody anti-gp70 were excised from SDS-PAGE gels and
tryptic digested for MS/MS identification and sequencing (Table
5). A 2D gel was also run to ascertain that the identified
peptides corresponded to a single component, gp70 (data not
shown). In addition, a purified gp70 antigen [28] was also
sequenced to confirm the peptide sequences (Table 5).
The identified peptide sequences shown in Table 5 were
deposited at EMBL-EBI as corresponding to cell wall gp70 for
both Sporothrix species. The identification was based on the
genome databases of S. schenckii and S. brasiliensis
(unpublished results), and the sequences correspond to the
ORFs Ss06314 and Sb05019, respectively. Interestingly, these
sequences present a 3-carboxymuconate cyclase domain
Table 2. Evaluation of the progression of sporotrichosis caused by S. brasiliensis and S. schenckii in a subcutaneous murine
model.
Strain Disseminationa,b Secondary lesions Deathc
Regression of the
primary lesion Observations
 Lung Spleen     
Ss54 ++ ++ 1/5 1/5 2/5 Secondary open lesions along the tail; macroscopic lesions in the liver.
5110 ++ ++ 0/5 5/5 2/5 Inflammation in the paw and posterior leg joints (arthritis); macroscopic lesions inthe liver; all mice died within 60 days post-infection.
HUPE 114158 ++ ++ 2/4 1/4 0/4 Persistent cutaneous lesions (more than 80 days)
UFTM 01 + +/- 3/5 1/5 1/5 Persistent cutaneous lesions (more than 80 days); inflammation in the paw andjoints (arthritis); macroscopic lesions in the liver.
HUPE 114500 +/- + 1/5 0/5 0/5 Persistent cutaneous lesions (more than 80 days)
IPEC 17943 +/- +/- 0/5 0/5 4/5 −
1099-18 + + 0/5 0/5 4/5 −
IPEC 15383 +/- +/- 0/5 0/5 4/5 Secondary ulcerated lesions along the tail; inflammation in the posterior leg joints.
a. Dissemination was determined by CFU in lung and spleen specimens collected 40 days post-infection.
b. Relative CFU counts (+/-) 20 colonies; (+) 20 to 120 colonies and (++) >120 colonies per Petri dish (the tissue specimens were ressuspended in the same proportion g
tissue/mL).
c. Mortality up to 60 days post-infection.
doi: 10.1371/journal.pone.0075656.t002
Table 3. Morphometric characteristics of S. schenckii and S. brasiliensis conidia.
 S. schenckii S. brasiliensis
Clinical isolate 1099-18 IPEC 15383 IPEC 17943 5110
Area + SD (µm2)a 2.78 + 0.36 2.86 + 0.59 3.07 + 0.61b 3.81 + 0.58c
Morphology Elongated oval Elongated oval Oval Oval
Disposition of conidia Sessile Sympodial Sympodial Sessile/sympodial
a. SEM morphometric analysis was performed with a mean of 34 conidia per isolate.
b. p<0.05 compared with S. schenckii isolates.
c. p<0.05 compared with S. schenckii isolates and IPEC 17943.
doi: 10.1371/journal.pone.0075656.t003
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Figure 2.  Morphology and morphometry of the mycelial phase of S. schenckii and S. brasiliensis clinical isolates.  (A, B)
Scanning electron microscopy of 1099-18 and IPEC 15383 strains of S. schenckii, respectively; (C, D) Scanning electron
microscopy of IPEC 17943 and 5110 strains of S. brasiliensis, respectively. (E) Morphometric analysis of S. schenckii and S.
brasiliensis conidia showing the cell mean size (+/- standard deviation). Forty five conidial cells of each strain were analyzed. *p<
0.05 relative to the S. brasiliensis isolates; ** p< 0.05 relative to the 5110 isolate.
doi: 10.1371/journal.pone.0075656.g002
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(Figure 8), an enzyme involved in benzoate degradation. The
gp70 gene encodes a 1,242bp and 1,239bp ORF interrupted
by a 64bp intron in S. schenckii (Genbank accession number
KF275147) and S. brasiliensis (Genbank accession number
KF275146), respectively.
According to InterPro analysis, these genes contain a signal
peptide (1-21 aa), a WD40/YVTN repeat-like-containing
domain (39-235 aa) and a 3-carboxy-cis,cis-muconate
lactonizing enzyme domain (256-411 aa) (Figure 8). Analysis
by the SignalIP 4.1 predictor shows the presence of a
canonical secretion signal, while an analysis using the BIG-PI
Fungal predictor indicates the lack of a GPI anchor (data not
shown). Furthermore, gp70 was investigated for the presence
in its sequence of potential glycosylation and phosphorylation
sites using the EnsembleGly and NetPhos software,
respectively. Interesting differences were observed, as the
gp70 of S. brasiliensis shows three putative O-glycosylation
sites while only one was predicted for the S. schenckii
glycoprotein. The number of predicted N-glycosylation sites is
similar with slight differences in the sequences inferred by the
EnsembleGly algorithm (Figure 8). NetPhos analysis
suggested that gp70 of both species has 20 putative
phosphorylation sites.
Discussion
Until recently, sporotrichosis was known as a benign
subcutaneous mycosis caused by a single etiological agent, S.
schenckii stricto sensu. This clinical and epidemiological panel
has changed dramatically with the emergence of S.
brasiliensis, a cryptic species of the S. schenckii complex,
which is predominant in Brazil [10,15]. S. brasiliensis is related
not only to the zoonotic transmission of this disease but also to
the emergence of severe cases of sporotrichosis [37-39]. One
question that arises is whether S. schenckii and S. brasiliensis
share similar virulence factors and/or have the same
pathogenicity. To attempt to answer this question, at least in
part, several clinical isolates of S. brasiliensis were analyzed in
the present work for their virulence capacity in a subcutaneous
murine model compared with two S. schenckii reference
strains. Six clinical isolates of S. brasiliensis were used in this
study, two of which have been previously described [14,38].
For all other clinical isolates, a phylogenetic distribution was
established to group them into the corresponding cryptic
species inside the Sporothrix spp. (Figure S1). Four strains
were further deposited in the American Type Culture Collection
(ATCC) with the following reference numbers: ATCC
MYA-4820 (S. schenckii IPEC 15383), ATCC MYA-4821 (S.
schenckii 1099-18), ATCC MYA-4823 (S. brasiliensis 5110)
and ATCC MYA-4824 (S. brasiliensis IPEC 17943). A
morphometric study was also performed with either conidia or
yeast cells of these four strains. Interestingly, the conidial
morphology of these organism supports differences found in
the phylogenetic distribution because S. brasiliensis presented
only oval conidia and S. schenckii isolates presented both
elongated and oval conidia.
A subcutaneous murine model of infection was established
to compare the virulence and dissemination capacity of the six
S. brasiliensis clinical isolates that were originally associated
with distinct hosts and/or clinical manifestations of
sporotrichosis. The results show that, with one exception (S.
brasiliensis IPEC17943), all other clinical isolates of S.
brasiliensis had increased pathogenicity compared with S.
schenckii. Furthermore, several parameters that could be
related to the differences observed in the virulence of S.
brasiliensis were investigated.
In a previous study, it was shown that several antigens
secreted by S. schenckii istricto sensu were able to induce a
specific humoral response in infected animals, specially the
antigen of 70 kDa (gp70), indicating a plausible participation of
specific antibodies against this molecule in the control of
infection [28,40]. Nascimento and co-workers had studied the
M64 strain (S. schenckii, ATCC MYA-4822), which was unable
to kill infected mice in a murine model of disseminated
sporotrichosis [28]. Altogether, the observations indicate that a
protective immune response during infection can be associated
with the cell wall gp70-expressing isolates, although the
outcome of the infection cannot be limited to a single antigen or
adhesin [24].
The importance of this glycoprotein during infection was
demonstrated by the treatment of mice infected with S.
schenckii with a monoclonal antibody against gp70. The results
showed a significant reduction in the number of CFUs in the
organs of mice when the mAb was injected before and during
S. schenckii infection [28]. A recent study demonstrated that
the fungicidal ability and TNF-α production of macrophages
increased when the fungus was phagocytized in the presence
of immune-inactivated serum or mAb P6E7 [41]. It is tempting
to speculate that anti-gp70-mediated phagocytosis may be
essential to macrophage killing, consequently producing TNF-α
to control the sporotrichosis. This molecule also acts as an
adhesin and interacts with fibronectin, an extracellular matrix
protein [24]. These observations indicate that gp70 can play a
Table 4. Morphometric characteristics of yeast cells of S. schenckii and S. brasiliensis clinical isolates.
 S. schenckii S. brasiliensis
Clinical isolate 1099-18 IPEC 15383 IPEC 17943 5110
Area + SD (µm2)a 4.18 + 2.03 4.60 + 1.44 3.38 + 1.53b 4.28 + 1.16
Morphology elongated elongated elongated oval
a. SEM morphometric analysis was performed with a mean of 58 yeast cells per isolate
b. p<0.05, compared with all other isolates.
doi: 10.1371/journal.pone.0075656.t004
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Figure 3.  Morphology and morphometry of the yeast phase of S. schenckii and S. brasiliensis clinical isolates.  (A, B)
Scanning electron microscopy of 1099-18 and IPEC 15383 of S. schenckii, respectively; (C, D) IPEC 17943 and (D) 5110, S.
brasiliensis Scanning electron microscopy of IPEC 17943 and 5110 strains of S. brasiliensis, respectively. (E) Morphometric
analysis of yeast cells of S. schenckii and S. brasiliensis isolates showing the cell mean size (+ standard deviation). Fifty eight yeast
cells of each strain were analyzed. * p< 0.05 relative to all other isolates.
doi: 10.1371/journal.pone.0075656.g003
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dual role in the host-fungus interplay and could be compared,
in its function, to a well described immunodominant antigen of
the dimorphic fungus Blastomyces dermatitidis, BAD-1. BAD-1
protein which is a secreted and cell surface-localized virulence
factor play a role as both an adhesin and immunomodulatory
molecule [42,43].
Our hypothesis was that the cell surface gp70 antigen could
have a direct association with the virulence profile of the
pathogenic species within the S. schenckii complex. No
previous reports had proven the presence or expression of
gp70 in S. brasiliensis. In the present study, gp70 was immune-
localized on the surface of two clinical isolates of S. brasiliensis
that were selected because they exhibit lower and higher
virulence capacity in a subcutaneous murine model. The
results show that a greater expression of gp70 on the fungal
surface correlates with a lower virulence profile of the strain. In
addition, a western blot approach was applied to relatively
quantify the differences in the gp70 cell wall expression of all S.
Figure 4.  Scanning electron microscopy (SEM) of the cell surface of S. schenckii and S. brasiliensis yeast cells.  (A, E)
1099-18; (B, F) IPEC 15383; (C, G) IPEC 17943 and (D, H) 5110. For the 1099-18, IPEC 15383 and 5110 strains the outer cell
layer shows a dense amorphous fibrillar material. The white arrow indicates a cell wall fracture observed in the IPEC 17943 strain.
(A-D) Scale bar -1.0 µm.
doi: 10.1371/journal.pone.0075656.g004
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brasiliensis clinical isolates and its relation to the severity of the
infection. A clear correlation was observed, as a reduced level
of gp70 expression was found in all virulent S. brasiliensis
isolates. This finding could represent a misbalance in the
Figure 5.  Gp70 expression on the cell wall of S. schenckii and S. brasiliensis clinical isolates.  The expression of gp70 in cell
wall extracts (see Methods) was verified by western blot analysis of S. schenckii 1099-18 (A) and IPEC 15383 (B); and (C) of S.
brasiliensis IPEC 17943 (C) and 5110 (D). The amount of protein loaded was 5 µg (A-C) and 15µg (D). (E-M) Scanning electron
microscopy showing the backscattered electron imaging (I-M) of yeast cells of S. schenckii 1099-18 (E, I), IPEC 15383 (F, J) and of
S. brasiliensis IPEC 17943 (G, L) and 5110 (H, M) which were incubated with a monoclonal antibody anti-gp70 followed by a mouse
anti-IgG gold-conjugate. E-H, Scale bar 1.0 µm.
doi: 10.1371/journal.pone.0075656.g005
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immune response, as this antigen induces a protective host
response [44]. Accordingly, the S. schenckii clinical reference
strains of different geographical origins (IPEC 15383 and
1099-18), which were both less virulent in the subcutaneous
murine model, presented high expression of gp70. No
differences in the cell surface topography or cell morphometry
were observed in S. schenckii. The low virulence isolate of S.
brasiliensis, IPEC17943, parallels the virulence profile and
gp70 expression of S. schenckii.
The identities of the gp70 antigen of S. schenckii and S.
brasiliensis were further investigated using proteomics.
Previously, Nascimento and co-workers [28] suggested a
possible amino acid sequence for the gp70 exoantigen based
on a peptide mass fingerprint and MS/MS data without any
available S. schenckii genomic database, which could be used
to perform a confident protein identification. In the present
work, the genome database of S. schenckii and S. brasiliensis
(unpublished results) was used to perform an accurate
identification of gp70 using MALDI-ToF/MS. The identification
of gp70 on cell wall extracts of either S. schenckii or S.
brasiliensis allowed us to align the protein sequences and
observe differences in their primary structure. The gp70 gene
encodes a carboxy-cis,cis-muconate cyclase (EC 5.5.1.5)
present in the β-ketoadipate pathway, as illustrated in Figure
S5. In filamentous fungi, this enzyme plays a key role in the
metabolism of aromatic compounds to produce acetyl-CoA,
which is processed by the TCA cycle [45]. Surprisingly, in the
tomato wilt pathogen Fusarium oxysporum f. sp. lycopersici,
mutants of carboxy-cis,cis-muconate cyclase are impaired in
root invasion and are nonpathogenic. The authors hypothesize
that the β-ketoadipate pathway in plant-pathogenic, soil-borne
fungi is necessary to degrade phenolic compounds in roots to
establish disease [46]. In the case of human pathogens, the
function of this enzyme remains unknown. The evidence shown
here that this glycoprotein is localized to several subcellular
locations, including the cell surface, may suggest that gp70 can
play a dual role depending on its cellular localization in the
fungal cell. This would not be the first time that a secreted and
cell associated protein would be involved in adhesion and
immunomodulation of host response, as mentioned before [42].
Furthermore, differences in the putative glycosylation sites of
gp70 were observed when comparing the entire sequences of
this glycoprotein from S. schenckii and S. brasiliensis. No
evidence of a GPI anchor was found according to the predictor
BigPI. Interestingly, the protein has a predicted secretion
signal. It is plausible to infer that the differences in fungal
virulence may also be related to the presence of gp70 isoforms
or glycoforms rather than being limited to its expression levels.
Other cell surface differences were observed between S.
schenckii and S. brasiliensis, as shown by SEM and MET, and
will need further investigation.
Here, for the first time, the identification, expression level and
subcellular localization of gp70 of S. brasiliensis and S.
schenckii and its possible correlation with the virulence profile
of these pathogenic species are reported.
Figure 6.  Western blot analysis of the cell surface gp70 of S. brasiliensis.  The gp70 antigen was revealed on cell surface
extracts of the yeast parasitic phase of two S. schenckii reference strains (lanes 1 and 2) and several clinical isolates of S.
brasiliensis (lanes 3 to 8) by a monoclonal antibody anti-gp70, mAb P6E7. A purified gp70 was used as a positive control and in C is
shown the negative control of the mAb P6E7. Correspondent strains in lanes (1) 1099-18; (2) IPEC 15383; (3) IPEC 17943; (4)
5110; (5) Ss 54; (6) UFTM 01; (7) HUPE 114500 and (8) HUPE 114158. The amount of protein loaded in lanes 1 to 8 was 5 µg..
doi: 10.1371/journal.pone.0075656.g006
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Figure 7.  Distribution and subcellular localization of gp70 on yeast cells of Sporothrix clinical isolates.  Transmission
electron micrograph of S. schenckii or S. brasiliensis yeast cells incubated with the monoclonal anti-gp 70 antibody followed by a
mouse anti-IgG gold-conjugated antibody. Is shown in (A) S. schenckii 1099-18, (B) S. schenckii IPEC 15383, (C) S. brasiliensis
IPEC 17943 and (D) S. brasiliensis 5110. Arrows indicate localization of gp70 on the cell wall (black arrows), in the cytoplasm (white
arrows) and at the extracellular compartment (arrowheads). Images featured were digitally magnified.
doi: 10.1371/journal.pone.0075656.g007
Cell Wall Gp70 and Virulence in S. brasiliensis
PLOS ONE | www.plosone.org 14 October 2013 | Volume 8 | Issue 10 | e75656
Table 5. Identified peptide sequences of gp70 by MS/MS.
Sporothrix spp ORF Peptide
S. schenckii Ss06314 AVYVTSNTEHNSVVAIPIAR
  GPTNTVSHVFFSGDQETVFTTVK
  TVIPGQDATCWVAICPATHTAFVTDIR
  KPVQHALLTPLGLDR
S. brasiliensis Sb05019 AVYVTSNTEHNSVVAIPIAR
  GPTNTVSHVFFSGDQETVFTTVK
  TVIPGQDATCWVAICPATHTAFVTDIR
  LVEMSLANAEIIGEPIDLTTFSNDPGLTEIR
  KPVQHALLTPLGLDR
doi: 10.1371/journal.pone.0075656.t005
Figure 8.  In silico characterization of gp70 in S. schenckii (1099-18) and S. brasiliensis (5110).  Identification of important
domains and putative glycosylation sitesin the gp70 protein sequence using InterPro and EnsembleGly. The gene and protein
sequences of gp70 were deposited in the GenBank and EMBL-EBI, respectively.
doi: 10.1371/journal.pone.0075656.g008
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Supporting Information
Figure S1.  Phylogenetic distribution of Sporothrix spp.
isolates through used for cell surface analysis and gp70
expression. Phylogenetic trees for cal locus was inferred using
the Maximum Likelihood and Nighbor-Joining methods.
Bootstrap values representing the branch fidelity were inferred
from 1000 replicates and added in the tree partitions.
Sequences representing type strains of S. schenckii, S.
brasiliensis and S. globosa were added for genotyping. Isolates
analyzed in this work are tagged with if clustered in S.
brasiliensis species or ● for S. schenckii clade.
(TIF)
Figure S2.  Scheme of the subcutaneous murine model of
sporotrichosis. The mycelium phase of Sporothrix spp was
cultivated in Sabouraud broth at 25°C. Conidia was isolated by
filtration in sterilized gauze and the cell number counted in a
Neubauer chamber. Thereafter, BALB/C male mice were
trichotomized in dorsal sacral region to undergo the
subcutaneous inoculation, as illustrated.
(TIF)
Figure S3.  Macroscopic aspect of the cutaneous lesions
caused by Sporothrix schenckii and Sporothrix
brasiliensis. Mice were inoculated with Sporothrix sp. conidia
and the progress of sporotrichosis was observed during 40
days, at least. The aspect of the primary lesion of mice infected
with each strain listed in Table 1 is shown at day 40th post-
infection.
(TIF)
Figure S4.  Histopahology showing the phagocytic
mononuclear reaction and the parasite burden in skin
specimens. (A, C and E) Hematoxylin and eosin stain and (B,
D and F) Grocott-gomori stain of skin specimens of mice
infected with (A, B) S. brasiliensis (strain IPEC 17493) showing
a poorly formed granuloma (black arrow); (C, D) S. brasiliensis
(strain 5110) showing a mononuclear infiltrate without
granuloma and a high fungal load in the tissue and, (E, F) S.
schenckii (strain 1099-18) showing a poorly formed granuloma
(black arrow) and few yeast cells.
(TIF)
Figure S5.  Characterization of gp70 by a genomic
approach. (A) Chemical reaction catalyzed by the carboxy-
cis,cis-muconate cyclase enzyme; (B) Distribution of carboxy-
cis,cis-muconate cyclase using Maximum Likelihood inferences
among Sordariomycete fungi.
(TIF)
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